Skip to main content
Innoviva, Inc. logo

Innoviva, Inc. — Investor Relations & Filings

Ticker · INVA ISIN · US45781M1018 LEI · 549300ACOX4QTBES6535 US Financial and insurance activities
Open in API
Filings indexed 1,226 across all filing types
Latest filing 2017-03-30 Proxy Solicitation & In…
Country US United States of America
Listing US INVA

About Innoviva, Inc.

https://www.inva.com/

Innoviva, Inc. is a diversified holding company that manages a portfolio of royalty-generating assets and operates a commercial-stage biopharmaceutical platform. The company's core royalty business is centered on respiratory therapies, providing a stable cash flow. Through its subsidiary, Innoviva Specialty Therapeutics, it focuses on developing and commercializing innovative treatments for patients in critical care and with infectious diseases. Innoviva's strategy involves leveraging its financial assets to invest in healthcare opportunities with high unmet medical needs, aiming to advance differentiated therapies and build a diverse portfolio of healthcare assets.

Recent filings

Filing Released Lang Actions
DFAN14A
Proxy Solicitation & Information Statement
2017-03-30 English
DFAN14A
Proxy Solicitation & Information Statement
2017-03-29 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a definitive proxy statement or definitive additional materials related to a shareholder meeting. It includes a letter from the Board of Directors urging shareholders to vote for the Board's nominees in an upcoming Annual Stockholder Meeting. The content focuses on proxy solicitation, board recommendations, and shareholder voting instructions. There is no financial report, earnings release, or audit information presented. The document is clearly a proxy solicitation material, which falls under the category of Proxy Solicitation & Information Statement (PSI). The document length (14,398 characters) and detailed content confirm it is not a brief announcement or a report publication announcement but the actual solicitation material.
2017-03-29 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a proxy statement or related materials filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. The text includes references to 'Definitive Additional Materials' related to a proxy statement, which are materials sent to shareholders to provide information and request votes for meetings. The content discusses legal proceedings related to books and records requests and court actions, but the filing type is clearly a proxy solicitation related document. The document length is 3419 characters, which is consistent with a proxy solicitation filing rather than a full annual report or other financial report. Therefore, the appropriate classification is Proxy Solicitation & Information Statement (PSI).
2017-03-29 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It contains detailed information about the upcoming annual shareholder meeting, including the Board of Directors' nominees, voting instructions, and arguments against a proxy fight initiated by a shareholder group. The document is clearly a solicitation for shareholder votes and includes proxy card instructions, which are typical features of proxy statements. It is not an annual report, earnings release, or any other financial report. The presence of the SEC header, the title 'Proxy Statement,' and the content focused on shareholder voting and board nominations confirm that this is a Proxy Solicitation & Information Statement filing.
2017-03-29 English
DEFA14A
Remuneration Information Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It contains detailed information related to the proxy solicitation for the company's annual meeting, including board nominees, shareholder voting matters, and other governance-related information. The presence of terms like 'Proxy Statement', 'Schedule 14A', and references to board nominees and shareholder meetings clearly indicate this is a proxy solicitation document. This type of filing corresponds to the Remuneration Information category (DEF 14A) as it typically includes executive compensation and director election information. The document length and content confirm it is not a brief announcement or a report publication announcement but the actual proxy statement filing with detailed materials. Therefore, the correct classification is DEF 14A with high confidence.
2017-03-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.